Nic Gillings
Nic Gillings
Department of Nuclear Medicine and PET, Rigshopsital
Verified email at
Cited by
Cited by
Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT2A agonist PET tracers
A Ettrup, M Hansen, MA Santini, J Paine, N Gillings, M Palner, S Lehel, ...
European journal of nuclear medicine and molecular imaging 38, 681-693, 2011
Kinetic modeling of 11C-SB207145 binding to 5-HT4 receptors in the human brain in vivo
L Marner, N Gillings, RA Comley, WFC Baaré, EA Rabiner, AA Wilson, ...
Journal of Nuclear Medicine 50 (6), 900-908, 2009
Serotonin 2A Receptor Agonist Binding in the Human Brain with [11C]Cimbi-36
A Ettrup, S da Cunha-Bang, B McMahon, S Lehel, A Dyssegaard, ...
Journal of Cerebral Blood Flow & Metabolism 34 (7), 1188-1196, 2014
Brain imaging of serotonin 4 receptors in humans with [11C] SB207145-PET
L Marner, N Gillings, K Madsen, D Erritzoe, WFC Baaré, C Svarer, ...
Neuroimage 50 (3), 855-861, 2010
The center for integrated molecular brain imaging (Cimbi) database
GM Knudsen, PS Jensen, D Erritzoe, WFC Baaré, A Ettrup, PM Fisher, ...
Neuroimage 124, 1213-1219, 2016
Specific Binding of [11C]Raclopride and N-[3H]Propyl-Norapomorphine to Dopamine Receptors in Living Mouse Striatum: Occupancy by Endogenous Dopamine …
P Cumming, DF Wong, N Gillings, J Hilton, U Scheffel, A Gjedde
Journal of Cerebral Blood Flow & Metabolism 22 (5), 596-604, 2002
EANM guideline on the validation of analytical methods for radiopharmaceuticals
N Gillings, S Todde, M Behe, C Decristoforo, P Elsinga, V Ferrari, ...
EJNMMI radiopharmacy and chemistry 5, 1-29, 2020
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals
N Gillings, O Hjelstuen, J Ballinger, M Behe, C Decristoforo, P Elsinga, ...
EJNMMI radiopharmacy and chemistry 6, 1-22, 2021
Evaluation of the Novel 5-HT4 Receptor PET Ligand [11C]SB207145 in the Göttingen Minipig
BR Kornum, NM Lind, N Gillings, L Marner, F Andersen, GM Knudsen
Journal of Cerebral Blood Flow & Metabolism 29 (1), 186-196, 2009
Serotonin 2A receptor agonist binding in the human brain with [11C] Cimbi-36: test–retest reproducibility and head-to-head comparison with the antagonist [18F] altanserin
A Ettrup, C Svarer, B McMahon, S da Cunha-Bang, S Lehel, K Møller, ...
Neuroimage 130, 167-174, 2016
Obesity is associated with high serotonin 4 receptor availability in the brain reward circuitry
ME Haahr, PM Rasmussen, K Madsen, L Marner, C Ratner, N Gillings, ...
Neuroimage 61 (4), 884-888, 2012
Binding characteristics of the 5‐HT2A receptor antagonists altanserin and MDL 100907
H Kristiansen, B Elfving, P Plenge, LH Pinborg, N Gillings, GM Knudsen
Synapse 58 (4), 249-257, 2005
The DaNeX study of embryonic mesencephalic, dopaminergic tissue grafted to a minipig model of Parkinson's disease: preliminary findings of effect of MPTP poisoning on striatal …
EH Danielsen, P Dimming, F Andersen, D Bender, T Brevig, L Falborg, ...
Cell Transplantation 9 (2), 247-259, 2000
Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET
A Ettrup, M Palner, N Gillings, MA Santini, M Hansen, BR Kornum, ...
Journal of Nuclear Medicine 51 (11), 1763-1770, 2010
5-HTTLPR status predictive of neocortical 5-HT4 binding assessed with [11C] SB207145 PET in humans
PM Fisher, KK Holst, B Mc Mahon, ME Haahr, K Madsen, N Gillings, ...
Neuroimage 62 (1), 130-136, 2012
A restricted access material for rapid analysis of [11C]-labeled radiopharmaceuticals and their metabolites in plasma
N Gillings
Nuclear medicine and biology 36 (8), 961-965, 2009
Simultaneous hyperpolarized 13C-pyruvate MRI and 18F-FDG-PET in cancer (hyperPET): feasibility of a new imaging concept using a clinical PET/MRI scanner
H Gutte, AE Hansen, ST Henriksen, HH Johannesen, ...
American journal of nuclear medicine and molecular imaging 5 (1), 38, 2015
Mass dose effects and in vivo affinity in brain PET receptor studies—a study of cerebral 5-HT4 receptor binding with [11C] SB207145
K Madsen, L Marner, M Haahr, N Gillings, GM Knudsen
Nuclear medicine and biology 38 (8), 1085-1091, 2011
On the consensus nomenclature rules for radiopharmaceutical chemistry–Reconsideration of radiochemical conversion
MM Herth, S Ametamey, D Antuganov, A Bauman, M Berndt, AF Brooks, ...
Nuclear medicine and biology 93, 19-21, 2021
Metabolic fate of hallucinogenic NBOMes
S Leth-Petersen, C Gabel-Jensen, N Gillings, S Lehel, HD Hansen, ...
Chemical research in toxicology 29 (1), 96-100, 2016
The system can't perform the operation now. Try again later.
Articles 1–20